Compare RANI & CVGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RANI | CVGI |
|---|---|---|
| Founded | 2012 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.8M | 123.9M |
| IPO Year | 2021 | 2004 |
| Metric | RANI | CVGI |
|---|---|---|
| Price | $1.07 | $3.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | 925.4K | ★ 1.2M |
| Earning Date | 05-12-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 21.05 | ★ 316.18 |
| EPS | N/A | ★ 0.04 |
| Revenue | $1,028,000.00 | ★ $755,231,000.00 |
| Revenue This Year | $414.59 | $3.08 |
| Revenue Next Year | $30.15 | $8.53 |
| P/E Ratio | ★ N/A | $93.25 |
| Revenue Growth | N/A | ★ 14.06 |
| 52 Week Low | $0.39 | $0.81 |
| 52 Week High | $3.87 | $3.80 |
| Indicator | RANI | CVGI |
|---|---|---|
| Relative Strength Index (RSI) | 36.41 | 75.87 |
| Support Level | $1.07 | $1.49 |
| Resistance Level | $1.54 | N/A |
| Average True Range (ATR) | 0.07 | 0.37 |
| MACD | -0.03 | 0.13 |
| Stochastic Oscillator | 17.14 | 90.81 |
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
Commercial Vehicle Group Inc and its subsidiaries are a globalised provider of systems, assemblies, and components to international commercial vehicle markets and electric vehicle markets. It delivers real solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities it serves. The company has its manufacturing operations in the United States, Mexico, China, the United Kingdom, the Czech Republic, Ukraine, Morocco, Thailand, India, and Australia. Organisations' products are mainly sold in North America, Europe, and the Asia-Pacific region. It has three segments: Global Seating Segment, Global Electrical systmem, and Trim Systems and Components Segment, with the majority of revenue from Global Seating Segment.